Antibody formulations and methods for treating AL amyloidosis
US9884020B2 · kind B2 · utility
2Cited by
112References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 27, 2016 |
| Grant date | Feb 6, 2018 |
| Priority date | — |
| Expiry date | Apr 27, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibody formulations and methods useful for prophylaxis or treatment of amyloidosis, including AA amyloidosis and AL amyloidosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.